EP3164155
TREPROSTINIL FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.6.2015EP published:
9.2.2022EP application number:
15731463.4
EPO information:
European Patent Register
Max expiry date:
11.6.2035
Title in English:
TREPROSTINIL FORMULATIONSLanguage of the patent:
English
Timeline
Today
12.6.2015EP application
9.2.2022EP Publication
Owner
Name:
United Therapeutics CorporationAddress:
1040 Spring Street, Silver Spring, MD 20910, US
Inventor
Name:
PHARES, KenAddress:
Hillborough, North Carolina 27278, US
Name:
CHANG, CourtneyAddress:
Raleigh, North Carolina 27617, US
Priority
Number:
201462011689 PDate:
13.6.2014Country:
US
Classification
Categories:
A61K 47/32, A61K 9/14, A61K 31/557, A61K 9/10, A61P 9/12